Open-House Original Discount Agreements 2026-10 Vemurafenib
Open-House-Originale-Rabattverträge 2026-10 Vemurafenib
Germany · Hamburg
What the buyer is looking for
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Vemurafenib im Rahmen eines Open-House-Verfahrens.
Description as published (DE).
Contract
BuyerTechniker Krankenkasse
TypeSupplies
Estimated valuevalue not published
Published20 August 2026
CategoryMedical equipment & pharma · CPV 33600000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Computacenter AG & Co. oHG | 76 | 2006–2026 |
| Siehe im Feld "Allgemeine Informationen" | 55 | 2023–2026 |
| Hexal AG · Holzkirchen | 43 | 2011–2026 |
| Aliud Pharma GmbH · Laichingen | 39 | 2011–2026 |
| neuraxpharm Arzneimittel GmbH · Langenfeld | 33 | 2011–2025 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
201986
202036
202122
202229
202354
2024263
20251
2025550
2026281
Who knows the rhythm prepares instead of reacting.
797
days until the deadline — Tuesday 31 October at 22:58
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Öffentliche Vergabe (Datenservice). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →